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A B S T R A C T
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:
To assess effects of oral care measures for preventing nursing home-acquired pneumonia in residents of nursing homes and other long-
term care facilities.
B A C K G R O U N D
Description of the condition
Residents of nursing homes and long-term care facilities are a pre-
dominantly geriatric population. Institutionalised elderly people
are prone to poor oral health because they have reduced access
to professional dental care and poor maintenance of personal oral
hygiene (Berg 2000; Gaszynska 2014). Many studies have found
that elderly people require professional oral hygiene care as well as
instruction on personal oral hygiene (e.g. Frenkel 2000;Gaszynska
2014; Gluhak 2010; Petelin 2012).
The incidence of community-acquired pneumonia (CAP) requir-
ing hospitalisation is 1.96 to 10 times higher amongst elderly
nursing home residents than community-dwelling elderly people
(Marrie 2002; Ronald 2008; Ticinesi 2016), with a 2.29 times
higher rate of 30-day mortality (Liapikou 2014). This may be at-
tributable to the particular characteristics of residents of nursing
homes and long-term care facilities, as they tend tobe older, to have
greater functional impairment and to have increased comorbidi-
ties, polypharmacy and dependence upon caregivers (Dudas 2000;
Martínez-Moragón 2004). Pneumonia occurring in residents of
long-term care facilities and nursing homes can be termed nursing
home-acquired pneumonia (NHAP); it closely resemblesCAPand
usually is caused by multi-drug-resistant bacteria (Craven 2006;
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Mylotte 2002), as indicated by data from the United States and
Asia (Micek 2007; Nakagawa 2014), although not confirmed by
European data (Brito 2009; Ewig 2010). Nursing home-acquired
pneumonia is the leading cause of mortality among residents (Cho
2011; Nicolle 1996). Its reportedmean incidence ranges from 1 to
3.2 per 1000 patient-days, with 600,000 emergency department
admissions (El-Solh 2010; Medina-Walpole 1999; Muder 1998).
It has been suggested that NHAP may be caused by aspiration of
oropharyngeal flora into the lung and by failure of host defence
mechanisms to eliminate aspirated bacteria (Scannapieco 2014;
Verghese 1983).
Comorbidities considered as risk factors for NHAP include the
following (Klapdor 2012; Ticinesi 2016):
• Cumulative Illness Rating Scale indexes;
• dementia;
• chronic obstructive pulmonary disease;
• mechanical ventilation; and
• ageing.
A growing body of evidence shows that poor oral hygiene and oral
hygiene-related factors (e.g. denture use (O’Donnell 2016), being
edentulous (Abe 2008)) may be additional risk factors for aspira-
tion pneumonia among the elderly, who have an increased rate of
dental plaque colonisation as a possible reservoir for pathogenic
organisms associated with CAP or NHAP (Bassim 2008; Janssens
2005; Scannapieco 2003). A systematic review by Azarpazhooh
2006 concluded that there was fair evidence (II-2, grade B recom-
mendation) of an association between pneumonia and oral health,
and good evidence (I, grade A recommendation) that better oral
health and frequent professional oral care reduce the occurrence or
progression of respiratory disease among high-risk elderly living in
nursing homes and especially those in intensive care units. How-
ever, an RCT by Juthani-Mehta 2015 indicated that advanced oral
care measures did not significantly reduce the incidence of first
radiographically-confirmed pneumonia or lower respiratory tract
infection compared with usual care in residents of nursing homes.
Given that NHAP may be linked to oral hygiene, interventions
for maintaining good oral hygiene might be of significant interest
in this population.
Description of the intervention
It is widely believed that improved oral hygiene and frequent pro-
fessional oral health care can be effective in reducing the inci-
dence or progression of respiratory infection in residents of nursing
homes and long-term care facilities (Adachi 2007; Azarpazhooh
2006; Scannapieco 2003; Sjögren 2008;Watando 2004).Multiple
oral care measures have been reinforced by the National Institute
for Health and Care Excellence (NICE) guideline that introduced
detailed oral care measures (NICE guideline 2016). The nature
of oral care measures that have been proposed is diverse, but they
can be classified broadly as follows.
• Mechanical aids to remove plaque and debris from the oral
cavity, for example:
◦ toothbrushing;
◦ swabbing with water.
• Topical (chemical) disinfection to reduce colonisation, for
example:
◦ mouthrinses;
◦ sprays;
◦ liquids;
◦ gels.
Antiseptics are broadly defined to include saline, chlorhexidine,
povidone-iodine and cetylpyridium and others, but to exclude
antibiotics (Shi 2013).
• Combination of mechanical plaque removal and topical
disinfection, for example:
• ◦ swabbing with antiseptic;
◦ toothbrushing with antibacterial toothpaste;
◦ daily toothbrushing plus antiseptic rinse.
• Professional dental care, for example:
◦ aided toothbrushing;
◦ suction to remove excess fluid.
Oral care measures can be delivered at any frequency. Oral health
measures can be delivered by carers, nurses, dental care profession-
als or dentists (Ekstrand 2013; Zuluaga 2012).
How the intervention might work
Increasing evidence suggests a link between colonisation of bac-
teria and respiratory infection and pneumonia. Gram-negative
bacilli (GNB), such as Pseudomonas aeruginosa, Klebsiella pneu-
moniae and Enterobacter spp., have been suspected as causative
pathogens of pneumonia (Craven 1992; Liapikou 2014). Depen-
dent and frail elderly patients have a higher detection rate of GNB
in their oropharyngeal cavities (Leibovitz 2003; Mylotte 1994;
Palmer 2001). Sumi 2007 showed that in a group of 138 de-
pendent elderly, a potential respiratory pathogen colonised the
dental plaques of 89 individuals (64.5%). Aspiration of oropha-
ryngeal fluid may cause translocation and colonisation of po-
tential pulmonary pathogens in the lower respiratory tract and
lungs (Gibbons 1989; Munro 2004; Whittaker 1996); the latter
may cause aspiration pneumonia (Van derMaarel-Wierink 2013).
Therefore, oral care measures that reduce the colonisation of bac-
teria could result in decreased risk of pneumonia.
The risk of NHAP might be reduced by measures that mechani-
cally disrupt the biofilm (such as manual or electric toothbrush-
ing) and/or by the use of oral antiseptics that may remain active
on oral tissues for several hours after application, reducing the
build-up of plaque. For example, chlorhexidine (CHX) gluconate
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is a broad-spectrum antiseptic agent that reduces both gram-pos-
itive and gram-negative bacteria associated with respiratory tract
infection; it can remain chemically active on tissue for up to six
hours (Tantipong 2008). Oral conditions of elderly people have
been shown to be improved by rinsing with 0.12% CHX solu-
tion daily or weekly for six weeks (DeRiso 1996; Persseon 1991).
Similarly, manual oral brushing improves oral hygiene by reduc-
ing bacterial pathogen colonisation, and improves the swallowing
reflex by stimulating gums (Yamaya 2001; Yoshino 2001). With
removal or disruption of the oral plaque, pneumonia could be
significantly reduced (Shi 2013; Van der Maarel-Wierink 2013).
Such oral care measures can be used alone or in combination. For
example, Yoshida 2001 found that tooth-brushing after each meal
and daily rinsing with 1% povidone-iodine in conjunction with
weekly professional dental care significantly decreased the inci-
dence of pneumonia in nursing homes.
Why it is important to do this review
Cochrane Oral Health undertook an extensive prioritisation ex-
ercise in 2014 to identify a core portfolio of clinically impor-
tant review titles to be maintained in The Cochrane Library
(Worthington 2015). The dental public health expert panel (http:/
/ohg.cochrane.org/priority-reviews) identified this review as a pri-
ority title.
Although good oral hygiene has been shown to play an important
role in maintaining the oral health and well-being of institution-
alised people, oral care measures have generally been afforded low
priority in nursing homes. In some guidelines, such as British Tho-
racic Society guidance on the prevention of CAP, oral hygiene is
not mentioned (Lim 2009). Moreover, nurses have limited knowl-
edge regarding provision of mouth care in general (Frenkel 2000;
Jablonski 2005; Pyle 2005). Chiba 2009 reported that 32.4% of
caregivers hesitated to provide oral care measures, which indicated
their lack of knowledge about oral hygiene but bespoke oral health
education has been shown to have a positive effect on caregivers’
knowledge and attitudes (Charteris 2001; Frenkel 2001; Frenkel
2002; Sjögren 2010). A systematic review by Kaneoka 2015 found
that mechanical oral cleaning significantly reduced the risk of fa-
tal pneumonia in residents in nursing homes. However, no other
kinds of oral care measures were evaluated, and no Cochrane sys-
tematic review has focused on this issue.
We believe it is important to synthesise the evidence from ran-
domised controlled trials of oral care interventions that have eval-
uated their effectiveness in reducing NHAP. Identifying effective
oral care interventions is also an essential step towards improving
oral health and quality of life for nursing home residents.
O B J E C T I V E S
To assess effects of oral caremeasures for preventing nursing home-
acquired pneumonia in residents of nursing homes and other long-
term care facilities.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We will include parallel randomised controlled trials (RCTs) as-
sessing the effects of oral care measures in residents of nursing and
other long-term care facilities. We will include cluster-RCTs, for
which the unit of randomisation is the care facility. We will ex-
clude cross-over studies.
Wu 2009has shown that studies carried out in China often use
the terminology of randomisation in a broader way than is usual
in other countries, such as the UK. Therefore, we will contact
the authors of trials written in Chinese to request a description of
the randomisation method used and will include only those trials
where participants’ allocation to treatment is random.
We will include all trials of oral care in which the purpose of the
study is to reduce the incidence of pneumonia. We will exclude
trials that report only intermediate outcomes, such as dental plaque
and gingivitis, without providing data on pneumonia.
We will not include studies for which the only available informa-
tion is presented in an abstract with no record of a full-text publi-
cation; this would provide insufficient information to enable full
assessment of risk of bias.
Types of participants
Residents of any age in nursing homes and other long-term care
facilities (e.g. rehabilitation units, medical care facilities), irrespec-
tive of oral health status (e.g. edentulous or dentate, using den-
tures, having physical or intellectual disabilities, being mechani-
cally ventilated, using alternative feeding route). We will exclude
participants with pneumonia or respiratory infection at baseline.
Types of interventions
We will include studies comparing oral care measure(s) for pre-
vention of NHAP versus no treatment, placebo, usual care or any
other oral care measure(s) used to prevent NHAP (head-to-head
studies).
• Intervention group: participant receives clearly defined oral
care measure(s), such as professional oral care (dentists/dental
hygienists/nurse-assisted tooth brushing), oral rinse or swab and
topical decontamination with antiseptics, regardless of frequency,
dosage or formulation.
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• Control group: participant receives placebo or another
specific oral care measure(s) or no treatment or usual care,
including self-care.
Use of topical antibiotics in the intervention group only makes a
study ineligible for inclusion in the review.
Types of outcome measures
Primary outcomes
• Incidence, incidence proportion or prevalence of NHAP of
any severity (diagnosis of NHAP should be based on radiological
results, clinical signs and symptoms, bacterial culture or some
synthetic criteria (American Thoracic Society 2005))
• Mortality (pneumonia-associated death)
• Mortality (all-cause death)
Secondary outcomes
• Change in systemic antibiotic use: This parameter includes
both number of participants who have used systemic antibiotics
and length of antibiotic use
• Adverse reactions to the interventions (both local and
systemic): This parameter refers to both numbers of participants
who have adverse reactions and numbers of adverse reactions
• Incidence or prevalence of fever: This will include
proportions of participants with fever higher than 37.8°C and
prolonged length of febrile days
• Change in data on economics and quality of life
• Oral health indices, such as gingival index, plaque index,
bleeding index, periodontal index, etc.
Search methods for identification of studies
Cochrane Oral Health’s Information Specialist will conduct sys-
tematic searches for randomised controlled trials and for controlled
clinical trials. We will place no restrictions on the language or date
of publication when searching electronic databases.
Electronic searches
We will search the following databases.
• Cochrane Oral Health Group Trials Register.
• Cochrane Central Register of Controlled Trials
(CENTRAL), in The Cochrane Library.
• MEDLINE Ovid (from 1946 onwards) (see Appendix 1).
• Embase Ovid (1980 onwards).
• Cumulative Index to Nursing and Allied Health Literature
(CINAHL) EBSCO (from 1937 onwards).
• Chinese Biomedical Literature Database (1978 to present).
• China National Knowledge Infrastructure (1994 to
present).
Searching other resources
We will search the following trials registries and databases.
• US National Institutes of Health Ongoing Trials Register
ClinicalTrials.gov (http://clinicaltrials.gov/).
• World Health Organization International Clinical Trials
Registry Platform (apps.who.int/trialsearch).
• Sciencepaper Online.
We will search the reference lists of included studies and review
articles for additional papers.
We will not perform a separate search for adverse effects of inter-
ventions. We will consider adverse effects described in included
studies only.
Review authors will scan records from19Chinese dental and nurs-
ing journals (2000 to 2010), as listed below.
• Chinese Journal of Stomatology.
• Journal of Practical Stomatology.
• Shanghai Journal of Stomatology.
• Journal of Clinical Stomatology.
• West China Journal of Stomatology.
• Journal of Modern Stomatology.
• Journal of Stomatology.
• Journal of Oral Science Research.
• Journal of Dental Prevention and Treatment.
• International Journal of Stomatology.
• Beijing Journal of Stomatology.
• Chinese Journal of Geriatric Dentistry.
• Chinese Journal of Nursing.
• Chinese Nursing Management.
• Nursing Journal of Chinese People’s Liberation.
• Journal of Nursing Science.
• Chinese Journal of Practical Nursing.
• Chinese Nursing Research.
• Modern Clinical Nursing.
Data collection and analysis
Selection of studies
Two review authors will independently screen the titles and ab-
stracts retrieved from the searches. We will independently assess
eligibility according to the inclusion criteria and will obtain full-
text copies of studies that appear to meet the inclusion criteria, or
when information in the title or the abstract is insufficient to per-
mit a clear judgement of eligibility. We will resolve disagreements
by discussion within the review author team.
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From the retrieved full-text articles, we will discard studies that
clearly donotmeet the inclusion criteria andwill record the reasons
for exclusion in the ’Characteristics of excluded studies’ tables.
Data extraction and management
Two review authors will carry out data extraction independently
and will resolve disagreements by discussion.
We will create a data extraction form and will pilot it on three of
the included studies. Two review authors will extract the following
data independently and will record them in the ’Characteristics of
included studies’ tables.
• Trial design with inclusion and exclusion criteria, duration,
setting and location of the study.
• Demographic data of participants and risk factors for
NHAP, including proportions of non-oral feeding, dysphagia,
xerostomia, tongue coating, mechanical ventilation and MRSA.
• Diagnostic criteria of CAP or NHAP: outcomes such as
incidence of NHAP and mortality; oral, dental and respiratory
health status before and after treatment; any adverse reactions
potentially relevant to the interventions; and timing of
measurement.
• Management and intensity of specific interventions.
If any important data are missing, we will contact the authors of
the study to request it. We wil collect data from duplicated studies
and will analyse these findings as from a single study.
Assessment of risk of bias in included studies
Two review authors will independently carry out risk of bias assess-
ments and will resolve disagreements by discussion. We will use
the tool for risk of bias assessment of The Cochrane Collaboration
(Higgins 2011a).
We will use seven domains to assess the risk of bias in included
studies. For each domain, we will provide information from the
trial report on what measures were taken to address possible bias
and a judgement of ’low risk’, ’unclear risk’ and ’high risk’ of bias.
We present the seven domains and their descriptions below.
• Random sequence generation: selection bias (biased
allocation to interventions) due to inadequate generation of a
randomised sequence. We will consider low risk of bias only if
the generation of random numbers is clearly described. We will
consider an unclear description of random sequence generation
with the phase “stratified randomisation”, “block randomisation
scheme” or “randomisation completed by statistician or nurse” as
having unclear risk of bias.
• Allocation concealment: selection bias (biased allocation to
interventions) due to inadequate concealment of the allocation.
• Blinding of participants and personnel: performance bias
due to knowledge of the allocated interventions by participants
and personnel during the study. We will judge studies with
completely different treatment arms when blinding was
apparently impossible as having high risk of performance bias,
even if details of blinding were not reported.
• Blinding of outcome assessment: detection bias due to
knowledge of allocated interventions by outcome assessors.
• Incomplete outcome data: attrition bias due to quantity,
nature or handling of incomplete outcome data.
• Selective reporting: reporting bias due to selective outcome
reporting.
• Other bias: bias due to problems not covered elsewhere in
the table, such as baseline imbalance, contamination and co-
intervention.
We will classify the overall risk of bias in included studies as in the
following table, and we will present this information as a ’Risk of
bias’ summary graphic.
Risk of bias Interpretation In outcome In included studies
Low risk of bias Plausible bias unlikely to seriously
alter the results
Low risk of bias for all key domains Most information is from studies at
low risk of bias.
Unclear risk of bias Plausible bias that raises some
doubt about the results
Unclear risk of bias for one or more
key domains
Most information is from studies at
low or unclear risk of bias
High risk of bias Plausible bias that seriously weak-
ens confidence in the results
High risk of bias for one or more
key domains
The proportion of information
from studies at high risk of bias is
sufficient to affect interpretation of
results
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Blinding of outcome assessment is less important for our objective
outcomes all-causemortality and pneumonia-associatedmortality.
We will consider this when assessing the quality of evidence on
mortality in ’Summary of findings’ tables.
Measures of treatment effect
Wewill treat the incidence proportion and prevalence of NHAP as
dichotomous data (presence/absence) and the incidence of NHAP
and mortality as time-to-event data when this has been reported,
or as dichotomous data when time to event is not reported. The
effect estimate for dichotomous outcomes will be the risk ratio
(RR) with 95% confidence interval (CI).
For time-to-event data, we will express the treatment effect as a
hazard ratio (HR) or a rate ratio. If HR is not reported, we will
calculate the log HR and the standard error from available sum-
mary statistics or Kaplan-Meier curves, according to the methods
proposed by Parmar 1998, or we will request the data from study
authors. If all measures fail, we will consider RR for time-to-event
datapresented as one-year survival, two-year survival and so on.
For continuous outcomes, when studies use the same scale, we
will use mean values and standard deviations (SDs) to express the
estimate of effect as mean difference (MD) with 95% confidence
interval (CI). When different scales are used to measure the same
outcome, we will use the standardised mean difference (SMD)
with 95% CI as the effect measure.
We consider it likely that few participants will have adverse reac-
tions; we will adopt the Peto odds ratio and the 95% CI as mea-
sures of treatment effect.
Unit of analysis issues
The unit of analysis adopted in this review will be the individual,
and we will analyse only participant-level data. For cluster-RCTs
analysed and reported by statistical measures that take clustering
into account, we will use the reported effect estimate and the stan-
dard error. When clustering has been ignored, we will attempt to
re-analyse study data using approximate analyses with an ’effec-
tive sample size.’ We will calculate and use external estimates of
the intracluster correlation coefficient (ICC) from similar studies
(when available) to calculate the design effect (Deeks 2011).
Dealing with missing data
Wewill contact the first and corresponding authors of the study to
request missing details. If these are not forthcoming, we will use
standard methods provided in the Cochrane Handbook for System-
atic Reviews of Interventions (Higgins 2011b) to extract approxi-
mate summary statistics from primary studies.
Assessment of heterogeneity
For each meta-analysis, we will assess clinical heterogeneity by ex-
amining characteristics of studies and similarities between types of
participants, interventions and outcomes. We will use Cochran’s
Q test to determine the presence of statistical heterogeneity at a
significance level of 0.1. We will use the I2 statistic (plus 95% con-
fidence interval) to quantify the degree of statistical heterogeneity
as follows.
• 0% to 40% may indicate slight heterogeneity.
• 30% to 60% may indicate moderate heterogeneity.
• 50% to 90% may indicate substantial heterogeneity.
• 75% to 100% may indicate very substantial heterogeneity.
If substantial or very substantial heterogeneity exists, we will pro-
vide a narrative description of the results instead of pooling data.
Assessment of reporting biases
To assess whether results are influenced by publication bias, wewill
construct a funnel plot to assess asymmetry (assuming we have at
least 10 studies). We will use tests for funnel plot asymmetry, such
as Egger’s methods for continuous data (Egger 1997), and Begg’s
methods for dichotomous and time-to-event data (Begg 1994).
Data synthesis
Wewill undertakemeta-analysis only when studies of similar com-
parisons report the same outcomes. Our general approach to evi-
dence synthesis will be to use a random-effects model. With this
approach, the CI for the average intervention effect is wider than
the value that would be obtained if a fixed-effect approach were
used, leading to a more conservative interpretation.
In an additional table, we will report the results from studies not
suitable for inclusion in meta-analysis.
Subgroup analysis and investigation of heterogeneity
To decide whether intervention effect is consistent across partic-
ipants or interventions with specific characteristics, we will con-
duct subgroup analyses. The main subgroup analysis will include
types of oral care measures. We will also consider study design
(cluster or parallel), length of follow-up, characteristics of partici-
pants (dentate or edentulous, with or without physical/intellectual
disabilities), characteristics of oral care measures (e.g. concentra-
tions of the solutions used, mechanical or topical intervention)
and diagnostic criteria of the outcome (clinical or radiological).
Sensitivity analysis
To test stability of judgements made during the review process, we
will undertake sensitivity analyses that include only studies at low
risk of bias or only studies using intention-to-treat (ITT) analysis.
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Assessing the quality of the evidence
We will assess the quality of the body of evidence for compar-
isons of clinical importance, such as different oral care drugs ver-
sus placebo; oral care measures versus no treatment; and nurse/
dentist-aided oral measures versus confrontational oral measures.
At least two of the review authors, with no conflicts of interest,
will use GRADE criteria and GRADE profiler software to inde-
pendently judge the quality of the evidence (Atkins 2004; Guyatt
2008; Schünemann 2011). Evidence from randomised controlled
trials is initially judged to be of high quality, but our confidence in
the body of evidence may be decreased owing to study limitations
(risk of bias), indirectness of the evidence, heterogeneity, impre-
cision of effect estimates and risk of publication bias (see above
Assessment of reporting biases). We will classify the quality of a
body of evidence into one of four categories: high, moderate, low
or very low (Guyatt 2008).
Summarising findings
We will present all important comparisons and primary outcomes
in the ’Summary of findings’ (SoF) table(s), together with illus-
trative comparative risks (which will be based on epidemiological
data on the prevalence of NHAP if robust data are available, or
will be based on the included studies); relative effect; numbers
of participants and studies involved; quality of the evidence; and
related comments. We will also include information pertaining to
adverse events.
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A P P E N D I C E S
Appendix 1. MEDLINE via Ovid Search Strategy
1. exp Preventive dentistry/
2. exp Dentifrices/
3. Mouthwashes/
4. Oral health/
5. Anti-infective agents, local/
6. Cetylpyridinium/
7. Chlorhexidine/
8. Povidone-iodine/
9. ((oral or mouth or dental) adj3 (care or hygiene or health)).ti,ab.
10. (care adj3 teeth).ti,ab.
11. (denture$ adj5 (clean$ or clens)).ti,ab.
12. (plaque adj3 (control$ or remov$)).ti,ab.
13. (mouthwash$ or mouth-wash$ or mouthrins$ or mouth-rins$ or oral-rins$ or toothpaste$ or “tooth paste$” or dentifrice$ or
toothbrush$ or “tooth brush$” or fluorid$ or chlorhexidine or betadine$ or triclosan or cepacol or Corsodyl or Peridex or Hibident
or Prexidine or Parodex or Chlorexil or Peridont or Eludril or Perioxidin or Chlorohex or Savacol or Periogard or Chlorhexamed or
Nolvasan or Sebidin or Tubulicid or hibitane).ti,ab.
14. (antiseptic$ or antiinfect$ or “local microbicide$” or “topical microbicide$”).ti,ab.
15. ((oral or mouth or dental) adj5 (foam$ or gel$)).ti,ab.
16. (floss$ or “interdental brush$” or (tooth adj5 clean$) or (teeth adj5 clean$) or (denture$ adj5 hygien$) or (tongue$ adj5
scrap$)).ti,ab.
17. “professional oral health care”.ti,ab.
18. or/1-17
19. exp Pneumonia/
20. pneumonia.ti,ab.
21. (“gram negative bacilli” or “pseudomonas aeruginosa” or “pseudomonas aruginosa” or enterobacter$ or pneumonitis or
“pulmonary inflammation” or “lung inflammation”).ti,ab.
22. or/19-21
23. 18 and 22
The above subject search will be linked to the Cochrane Highly Sensitive Search Strategy (CHSSS) for identifying randomised trials in
MEDLINE: sensitivity-maximising version (2008 revision) as referenced in Chapter 6.4.11.1 and detailed in box 6.4.c of The Cochrane
Handbook for Systematic Reviews of Interventions, Version 5.1.0 [updated March 2011] (Lefebvre 2011).
1. randomized controlled trial.pt.
2. controlled clinical trial.pt.
3. randomized.ab.
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4. placebo.ab.
5. drug therapy.fs.
6. randomly.ab.
7. trial.ab.
8. groups.ab.
9. or/1-8
10. exp animals/ not humans.sh.
11. 9 not 10
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